PRESENT-DAY advances in psychotherapy have added impetus to investigations into the actions of drugs which affect the central nervous system and thus cause changes in behaviour patterns. One such ...

THE marked aberrations in mental functions produced by minute doses of lysergic acid diethylamide (LSD-25) resemble aspects peculiar to schizophrenia 1,2. As a result the drug has been suggested to be ...

Malformations of the brain, spinal cord, liver, and other viscera; body edema; and localized hemorrhages were found in fetal hamsters from mothers injected subcutaneously with a single dose of ...

This is a preview. Log in through your library . Abstract RNA synthesis in isolated brain nuclei was analyzed 2.5 hr after the intravenous administration of d-lysergic acid diethylamide (LSD) to young ...

— Study Published in Psychopharmacology and Presented at the 12 th Clinical Trials on Alzheimer’s Disease (CTAD) Shows Favorable Safety and Tolerability Profile of Regular Low Dose LSD —Scientific ...

NO drug used by man has stimulated greater public-debate than lysergic acid diethylamide (LSD). This brief review of the current status of the drug will summarize its pharmacology, medical uses and ...

Drugs targeting receptors of the neurotransmitter serotonin (5-hydroxytryptamine [5-HT]) are widely used in neuropsychiatry and some such agents, most notably psilocybin, have shown potential for ...

Patterns and trends in incidence, survival, and treatment among patients with early-onset lung cancer in the U.S.: A population-based study. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...

Acid is human-made and developed from a substance found in ergot, which is a fungus. Its name is lysergic acid diethylamide (LSD), and it can last up to 12 hours Acid is a colorless, odorless liquid.

Texas passed a landmark law in June 2025, supported by former Gov. Rick Perry, that allocates US$50 million to support research on ibogaine, one of the most powerful psychedelics, for treating opioid ...